IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Turkey

  • ID: 1408499
  • Report
  • Region: Turkey
  • 41 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

Turkey

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Universal Health Insurance Scheme
  • Private Health Insurance
  • Regulation, Funding & Provision
  • Syrian Refugee Crisis

2. Pricing

  • Prescription Drugs
  • Applications
  • Price Evaluation Commission
  • International Reference Pricing
  • Mandatory Discounts
  • Generic Drugs
  • Price Caps
  • Mandatory Manufacturer Discounts
  • Internal Reference Pricing
  • Hospital Drugs
  • Special Pricing Provisions
  • Actual Prices
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Assessment Process
  • Reimbursement Restrictions
  • Timelines
  • Alternative Reimbursement Commission
  • Reimbursement Categories
  • Reimbursement Prices
  • Mandatory Discounts
  • Internal Reference Price System
  • Hospital Reimbursement
  • Formularies
  • Funding
  • Changes in Reimbursement Status
  • Changes in Reimbursement Prices
  • Price Adjustments

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements

5. Price Build Up

  • Wholesalers
  • Margins
  • Background
  • Retail Pharmacies
  • Margins
  • Other Fees
  • Mandatory Discounts
  • Regulations
  • Hospital Drugs
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Patient Co-payments
  • Pharmaceuticals
  • Healthcare
  • Prescribing Controls
  • Electronic Prescriptions
  • Monitoring of Prescriptions
  • Treatment Guidelines
  • Prescribing Restrictions
  • Rational Drug Use
  • Generics
  • Rx-to-OTC Switches
  • Parallel Trade
  • Supply Shortages
  • Access to Imported Products

7. Future Developments

  • Outlook
  • New Pricing Legislation
  • Changes to the Imported Medicines Scheme
  • Diagnosis-related Groups

8. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll